dihydroxyphenylalanine has been researched along with 22q11.2 Deletion Syndrome in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogdaki, M | 1 |
| Devroye, C | 1 |
| Ciampoli, M | 1 |
| Veronese, M | 1 |
| Ashok, AH | 1 |
| McCutcheon, RA | 1 |
| Jauhar, S | 1 |
| Bonoldi, I | 1 |
| Gudbrandsen, M | 1 |
| Daly, E | 1 |
| van Amelsvoort, T | 1 |
| Van Den Bree, M | 1 |
| Owen, MJ | 1 |
| Turkheimer, F | 1 |
| Papaleo, F | 1 |
| Howes, OD | 1 |
1 other study available for dihydroxyphenylalanine and 22q11.2 Deletion Syndrome
| Article | Year |
|---|---|
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
Topics: DiGeorge Syndrome; Dihydroxyphenylalanine; DNA Copy Number Variations; Dopamine; Humans; Positron-Em | 2023 |